Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02584478 |
| Title | Phase 1/2a Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Advenchen Laboratories, LLC |
| Indications |
cervical adenosquamous carcinoma cervical squamous cell carcinoma ovarian clear cell adenocarcinoma |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |